Back to Search
Start Over
LABORATORY STUDIES TO DETERMINE THE HIGH DOSE STATUS OF VIPCOT™ COTTON.
LABORATORY STUDIES TO DETERMINE THE HIGH DOSE STATUS OF VIPCOT™ COTTON.
- Source :
- Proceedings of the Beltwide Cotton Conferences; 2007, p1087-1094, 8p, 2 Charts, 4 Graphs
- Publication Year :
- 2007
-
Abstract
- Syngenta is currently developing VipCot™, a transgenic insect-resistant cotton that expresses both Vip3A and Cry1Ab insecticidal proteins. These proteins were combined through the traditional breeding of two independent events, each expressing one of the two proteins. The mode-of-action of Vip3A is different from that of Cry1Ab, and there is no cross-resistance between these proteins. Therefore, from an Insect Resistance Management (IRM) perspective, a stack of Vip3A and Cry1Ab will represent an excellent and sustainable product for cotton lepidopteran pest control. We are currently evaluating the high dose status of VipCot™ to support the IRM strategy proposed for the product. In this paper, data from two laboratory-based methods assessing the high dose status of VipCot™ are presented. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- Database :
- Supplemental Index
- Journal :
- Proceedings of the Beltwide Cotton Conferences
- Publication Type :
- Conference
- Accession number :
- 36953338